U.S. federal trademark · Serial No. 77788294
Diagnostic and prognosis testing kits composed primarily of antibodies, assays and biochemical reagents used in the field of cancer, all the aforesaid goods intended for medical diagnostic purposes; assays that measure genetic markers and/or proteins for evaluating the molecular profile of malignant tumors to determine the risk of recurrence and predict the need for and response to cancer therapies
testing, analyzing and evaluating malignant tumor biopsies, circulating tumor cells, and cancer cells
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.